BE904921A - Procedes et compositions pour le traitement de troubles gastro-intestinaux. - Google Patents

Procedes et compositions pour le traitement de troubles gastro-intestinaux.

Info

Publication number
BE904921A
BE904921A BE0/216782A BE216782A BE904921A BE 904921 A BE904921 A BE 904921A BE 0/216782 A BE0/216782 A BE 0/216782A BE 216782 A BE216782 A BE 216782A BE 904921 A BE904921 A BE 904921A
Authority
BE
Belgium
Prior art keywords
bismuth
pref
antimicrobial
days
administered
Prior art date
Application number
BE0/216782A
Other languages
English (en)
Original Assignee
Marshall Barry J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marshall Barry J filed Critical Marshall Barry J
Publication of BE904921A publication Critical patent/BE904921A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Procédé pour le traitement d'un etre humain ou d'un animal inférieur souffrant d'un trouble gastrointestinal, caractérisé en ce que l'on administre au sujet en question d'environ 50 mg à environ 5000g de bismuth, par jour, pendant une durée de 3 à 56 jours et on administre au sujet en question une quantité sure et efficace d'un agent antimicrobien par jour, pendant une période qui fluctue de 1 à 21 jours.
BE0/216782A 1985-06-13 1986-06-13 Procedes et compositions pour le traitement de troubles gastro-intestinaux. BE904921A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74484185A 1985-06-13 1985-06-13

Publications (1)

Publication Number Publication Date
BE904921A true BE904921A (fr) 1986-12-15

Family

ID=24994175

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/216782A BE904921A (fr) 1985-06-13 1986-06-13 Procedes et compositions pour le traitement de troubles gastro-intestinaux.

Country Status (11)

Country Link
EP (3) EP0462631B1 (fr)
JP (1) JPH0794390B2 (fr)
AT (3) ATE318144T1 (fr)
AU (1) AU588601B2 (fr)
BE (1) BE904921A (fr)
CA (1) CA1277232C (fr)
DE (4) DE3686836T2 (fr)
IE (1) IE59583B1 (fr)
NZ (1) NZ216516A (fr)
PH (1) PH25288A (fr)
ZA (1) ZA864449B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005981A1 (fr) * 1985-04-18 1986-10-23 Borody Thomas J Traitement de la dyspepsie non ulcereuse avec des sels de bismuth
US4959384A (en) * 1985-10-24 1990-09-25 Norwich Eaton Pharmaceuticals, Inc. Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
DE3874917T2 (de) * 1987-03-09 1993-03-04 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
EP0439453B1 (fr) * 1987-10-12 1994-01-19 Exomed Australia Pty. Ltd. (ACN 051 976 446) Procede ameliore servant au traitement de troubles gastrointestinaux
ATE67669T1 (de) * 1988-10-08 1991-10-15 Pfleger R Chem Fab Fluessiges, wismuthaltiges arzneipraeparat, verfahren zum herstellen desselben und seine verwendung.
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
EP0375068A1 (fr) * 1988-12-23 1990-06-27 Gist-Brocades N.V. Associations de composés de bismuth et de tétracyclines
DE3901508C2 (de) * 1989-01-19 1994-04-07 Falk Pharma Gmbh Arzneimittel auf der Grundlage eines Wismut enthaltenden Präparats in fester Form
FI910088A (fi) * 1990-01-09 1991-07-10 Gist Brocades Nv Oral farmaceutisk komposition.
YU45590A (sh) * 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
JPH06509340A (ja) * 1991-07-24 1994-10-20 ザ、プロクター、エンド、ギャンブル、カンパニー 抗菌治療方法及び組成物
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
AU7833194A (en) * 1993-09-20 1995-04-10 Procter & Gamble Company, The Use of triclosan phosphates for the treatment of gastrointestinal disorders due to heliobacter infection
FR2715067B1 (fr) * 1994-01-14 1996-04-05 Ethypharm Lab Prod Ethiques Nouvelle forme galénique de dérivés de 5-nitro-imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus gastro-intestinal.
US5549911A (en) * 1994-01-14 1996-08-27 Laboratoires Des Produits Ethiques Ethypharm Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract
GB2293323A (en) * 1994-09-12 1996-03-27 Orion Yhtymae Oy Antibiotics and bismuth salts for treating bacterial infections
GB2292884A (en) * 1994-09-12 1996-03-13 Orion Yhtymae Oy Rifamycin & bismuth salts for treating bacterial infections
AUPN115095A0 (en) * 1995-02-15 1995-03-09 Butt, Henry Lawrence Analysis of and compositions and methods for the treatment of disease
EP0830135A1 (fr) * 1995-05-09 1998-03-25 The Procter & Gamble Company Compositions comprenant du bismuth et un ou plusieurs antimicrobiens, pour la prevention et le traitement de troubles gastro-intestinaux
US5702729A (en) * 1995-12-07 1997-12-30 The Procter & Gamble Company Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria
US6051604A (en) * 1995-12-07 2000-04-18 The Proctor & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US5744168A (en) * 1995-12-07 1998-04-28 The Procter & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US6186958B1 (en) 1997-02-26 2001-02-13 Oridion Medical Breath test analyzer
US6067989A (en) * 1997-02-26 2000-05-30 Oridion Medical, Ltd. Breath test for the diagnosis of Helicobacter pylori infection in the gastrointestinal tract
USRE38728E1 (en) * 1997-09-11 2005-04-19 Oridion Medical, LTD Breath test analyzer
WO1999043327A1 (fr) * 1998-02-24 1999-09-02 Kaneka Corporation Compositions antimicrobiennes a effet synergique, medicaments et remedes pour maladies digestives contenant ces compositions, leur procede de production et preparations associees
DE19850445A1 (de) * 1998-11-02 2000-05-04 Falk Pharma Gmbh Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
CN104666429A (zh) * 2013-11-28 2015-06-03 天津瑞贝特科技发展有限公司 治疗鸡腺胃炎的组合物及其制备方法
JP6487534B2 (ja) 2014-09-05 2019-03-20 シンビオミックス セラピューティクス、エルエルシー 細菌性膣炎の治療に使用するためのセクニダゾール

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1332522A (fr) * 1961-10-05 1963-07-19 Procédé pour préparer des composés résultant de la combinaison chimique de substances antibiotiques et de substances mycocides
US3395212A (en) * 1964-08-10 1968-07-30 American Cyanamid Co Neomycin and organobismuth antibacterial finish for cellulosic material
FR6531M (fr) * 1967-09-14 1968-12-09
US4153685A (en) * 1968-11-23 1979-05-08 Schering Corporation Bismuth complex preparations
FR2053002A1 (en) * 1969-06-21 1971-04-16 Clin Midy Bismuth slats of alpha methiminobenzyl - penicillin
DE1963496A1 (de) * 1969-12-18 1971-06-24 Hans Voigt Chemisch Pharmazeut Pharmazeutisches Praeparat zur Behandlung von Magen-Darm-Erkrankungen
US4118480A (en) * 1973-02-09 1978-10-03 Charles V. Stoelker Pharmaceutical preparation for treating hemorrhoids and anal fissures
US3903297A (en) 1973-11-01 1975-09-02 Upjohn Co Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs
ZA74385B (en) * 1974-01-18 1975-08-27 Gist Brocades Nv Pharmaceutical compositions
US4016268A (en) * 1975-10-06 1977-04-05 Morton-Norwich Products, Inc. Method of combatting gastric ulceration
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
PH20649A (en) * 1981-09-22 1987-03-16 Gist Brocades Nv Bismuth containing composition and method for the preparation thereof
US4588589A (en) * 1983-10-13 1986-05-13 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
WO1986005981A1 (fr) * 1985-04-18 1986-10-23 Borody Thomas J Traitement de la dyspepsie non ulcereuse avec des sels de bismuth

Also Published As

Publication number Publication date
ATE318144T1 (de) 2006-03-15
EP0462631B1 (fr) 1996-03-20
PH25288A (en) 1991-04-30
ATE81010T1 (de) 1992-10-15
AU588601B2 (en) 1989-09-21
IE861572L (en) 1986-12-13
EP0206625A2 (fr) 1986-12-30
AU5859586A (en) 1986-12-18
DE3686836T2 (de) 1993-03-04
DE3650787T2 (de) 2006-11-16
NZ216516A (en) 1989-08-29
JPS6248623A (ja) 1987-03-03
DE3650504T2 (de) 1996-10-31
EP0206625A3 (en) 1989-04-05
DE3650787D1 (de) 2006-04-27
EP0707854A2 (fr) 1996-04-24
JPH0794390B2 (ja) 1995-10-11
IE59583B1 (en) 1994-03-09
DE3619702A1 (de) 1987-02-12
DE3650504D1 (de) 1996-04-25
EP0462631A1 (fr) 1991-12-27
ATE135582T1 (de) 1996-04-15
CA1277232C (fr) 1990-12-04
DE3686836D1 (de) 1992-11-05
ZA864449B (en) 1987-02-25
EP0707854A3 (fr) 1997-06-04
EP0707854B1 (fr) 2006-02-22
EP0206625B1 (fr) 1992-09-30

Similar Documents

Publication Publication Date Title
BE904921A (fr) Procedes et compositions pour le traitement de troubles gastro-intestinaux.
Graham et al. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing: a randomized controlled trial
US5256684A (en) Methods and compositions for the treatment of gastrointestinal disorders
DE3887353T2 (de) Behandlungsverfahren für magen-darm-krankheiten.
AU590578B2 (en) Treatment of non-ulcer dyspepsia with bismuth salts
KR920002144A (ko) 아연 l-카르노신 염 또는 이의 착화합물을 유효성분으로 함유하는 염증성 장질환 예방 및 치료제
DE69125940T2 (de) Pharmazeutische zusammensetzungen die 5-difluormethoxy-2-[3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1h-benzimidazol und ein anti-heliobactermittel enthalten zur behandlung von magen-darm krankheiten
EP0865286B1 (fr) Compositions destinees a la prevention et au traitement de troubles gastro-intestinaux et comprenant du bismuth ainsi qu'un ou plusieurs agents antimicrobiens
RU2139060C1 (ru) Комплексный биологически активный препарат
Wise et al. Cephacetrile, a new cephalosporin, in the treatment of urinary tract infections
US4252821A (en) Method for treating ulcers
Evans Jr et al. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing
Gardikas et al. Cefuroxime in the treatment of urinary tract infections
MONASH et al. Bismuth penicillin in the treatment of acute syphilitic Orchitis of rabbits
Smoot et al. Effectiveness of Ranitidine Bismuth Citrate, Clarithromycin, and Metronidazole Therapy for TreatingHelicobacter pylori
Scarpignato et al. H2 Receptor Antagonists: Is There a Place in the Treatment of Helicobacter pylori Infection?
Study A Fixed Combination of Pivmecillinam and Pivampicillin in Complicated Urinary Tract Infections: Double-blind Comparison with Pivmecillinam Alone in Hospitalized Patients

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *MARSHALL BARRY J.

Effective date: 20060613